|
1.
|
|
14 p, 1.3 MB |
Diagnosis and management of migraine in ten steps
/
Eigenbrodt, Anna K. (University of Copenhagen) ;
Ashina, Håkan (University of Copenhagen) ;
Khan, Sabrina (University of Copenhagen) ;
Diener, Hans-Christoph (University Duisburg-Essen) ;
Mitsikostas, Dimos D. (Aeginition Hospital) ;
Sinclair, Alexandra J. (Birmingham Women's and Children's Hospital (Regne Unit)) ;
Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martelletti, Paolo (Sant'Andrea Hospital) ;
Ducros, Anne (University Hospital of Montpellier (França)) ;
Lantéri-Minet, Michel (Centre Hospitalo-Universitaire de Nice) ;
Braschinsky, Mark (Tartu University Hospital (Tartu, Estònia)) ;
Del Rio, Margarita Sanchez (Clínica Universidad de Navarra) ;
Daniel, Oved (Headache & Facial Pain Clinic) ;
Özge, Aynur (Mersin University Medical Faculty) ;
Mammadbayli, Ayten (Azerbaijan State Medical University, Baku, Azerbaijan) ;
Arons, Mihails (eStradins University) ;
Skorobogatykh, Kirill (University Headache Clinic, Moscow, Russia) ;
Romanenko, Vladimir (Ukrainian Institute of Family Medicine) ;
Terwindt, Gisela M. (Leiden University Medical Center) ;
Paemeleire, Koen (Universitair Ziekenhuis Gent) ;
Sacco, Simona (University of L'Aquila) ;
Reuter, Uwe (Charité - Universitätsmedizin Berlin) ;
Lampl, Christian (Ordensklinikum Linz) ;
Schytz, Henrik W. (University of Copenhagen) ;
Katsarava, Zaza (IM Sechenov First Moscow State Medical University) ;
Steiner, Timothy J. (Imperial College London) ;
Ashina, Messoud (Azerbaijan Medical University)
Migraine is a disabling primary headache disorder that directly affects more than one billion people worldwide. Despite its widespread prevalence, migraine remains under-diagnosed and under-treated. [...]
2021 -  10.1038/s41582-021-00509-5
Nature Reviews. Neurology, Vol. 17 (june 2021) , p. 501-514
|
|
|
2.
|
|
15 p, 678.4 KB |
Health technology assessment for the acute and preventive treatment of migraine : A position statement of the International Headache Society
/
Diener, Hans-Christoph (Institute for Medical Informatics, Biometry and Epidemiology, University Duisburg-Essen, Essen, Berlin, Germany) ;
Ashina, Messoud (University of Copenhagen) ;
Durand-Zaleski, Isabelle (Santé Publique Hôpital Henri Mondor, Créteil, France) ;
Kurth, Tobias (Charité - Universitätsmedizin Berlin) ;
Lantéri-Minet, Michel (Départment d'Evaluation et Traitement de la Douleur, CHU de Nice, FHU InovPain, Universite Cete Azur, Nice, France) ;
Lipton, Richard B. (Albert Einstein College of Medicine) ;
Ollendorf, Daniel A. (Value Measurement and Global Health Initiatives, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, , Boston, MA, USA) ;
Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Tassorelli, Cristina (Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy) ;
Terwindt, Gisela (Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands) ;
Universitat Autònoma de Barcelona
The Clinical Trials Subcommittee of the International Headache Society presents the first Health Technology Assessment for the Acute Treatment of Migraine Attacks and Prevention of Migraine. Health technology assessments are systematic evaluations of the properties, effects, and consequences of healthcare technologies; this position statement is designed to inform decision makers about access to and reimbursement for medications and devices for the acute and preventive treatment of migraine. [...]
2021 - 10.1177/0333102421989247
Cephalalgia, Vol. 41 (january 2021) , p. 279-293
|
|
|
3.
|
|
10 p, 964.3 KB |
Guideline on the use of onabotulinumtoxinA in chronic migraine : a consensus statement from the European Headache Federation
/
Bendtsen, Lars (University of Copenhagen) ;
Sacco, Simona (University of L'Aquila. Neuroscience Section, Department of Applied Clinical Sciences and Biotechnology) ;
Ashina, Messoud (University of Copenhagen) ;
Mitsikostas, Dimos (National and Kapodistrian University of Athens. 1st Department of Neurology, Aeginition Hospital) ;
Ahmed, Fayyaz (Hull York Medical School. Department of Neurosciences) ;
Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martelletti, Paolo (Sapienza University. Department of Clinical and Molecular Medicine) ;
Universitat Autònoma de Barcelona ;
Hospital Universitari Vall d'Hebron
OnabotulinumtoxinA is being increasingly used in the management of chronic migraine (CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional therapy with orally administered preventatives. [...]
2018 - 10.1186/s10194-018-0921-8
Journal of headache and pain, Vol. 19 (september 2018)
|
|
|
4.
|
|
13 p, 823.6 KB |
Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine : The multicentre, double-blind, randomised, sham-controlled PREMIUM trial
/
Diener, Hans-Christoph (University Duisburg-Essen) ;
Goadsby, Peter J. (King's College London) ;
Ashina, Messoud (Glostrup University Hospital Copenhagen) ;
Al-Karagholi, Mohammad Al-Mahdi (Glostrup University Hospital Copenhagen) ;
Sinclair, Alexandra J. (Metabolic Neurology, Institute of Metabolism and Systems Research, University of Birmingham) ;
Mitsikostas, Dimos (1st National and Kapodistrian University of Athens) ;
Magis, Delphine (CHR East Belgium) ;
Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Irimia Sieira, Pablo (Clínica Universidad de Navarra) ;
Làinez, Miguel J. A. (Universidad Católica de Valencia) ;
Gaul, Charly (Migraine and Headache Clinic) ;
Silver, Nicholas (The Walton Centre) ;
Hoffmann, Jan (King's College London) ;
Marin, Juana (King's College London) ;
Liebler, Eric (electroCore, Inc., Basking Ridge) ;
Ferrari, Michel D.. (Leiden University Medical Center) ;
Universitat Autònoma de Barcelona
Non-invasive vagus nerve stimulation (nVNS; gammaCore®) has the potential to prevent migraine days in patients with migraine on the basis of mechanistic rationale and pilot clinical data. This multicentre study included a 4-week run-in period, a 12-week double-blind period of randomised treatment with nVNS or sham, and a 24-week open-label period of nVNS. [...]
2019 - 10.1177/0333102419876920
Cephalalgia, Vol. 39 (september 2019) , p. 1475-1487
|
|
|
5.
|
|
24 p, 365.1 KB |
Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults : Fourth edition
/
Diener, Hans-Christoph (University Hospital Essen (Alemanya)) ;
Tassorelli, Cristina (University of Pavia) ;
Dodick, David W. (Mayo Clinic) ;
Silberstein, Stephen D. (Thomas Jefferson University) ;
Lipton, Richard B. (Albert Einstein College of Medicine) ;
Ashina, Messoud (University of Copenhagen) ;
Becker, Werner J. (University of Calgary) ;
Ferrari, Michel D.. (Leiden University Medical Center) ;
Goadsby, Peter J. (King's College London) ;
Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron) ;
Wang, Shuu-Jiun (National Yang-Ming University) ;
Mandrekar, Jay (Mayo Clinic Rochester) ;
Universitat Autònoma de Barcelona
The quality of clinical trials is an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for controlled trials of drugs in migraine. [...]
2019 - 10.1177/0333102419828967
Cephalalgia, Vol. 39 (february 2019) , p. 687-710
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
